The Effects of a Polymorphism in the Cytochrome P450 CYP1A2 Gene on Performance Enhancement with Caffeine in Recreational Cyclists
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: The purpose of the present study was to determine if a polymorphism in the cytochrome P450 CYP1A2 gene impacts performance enhancement with caffeine treatment in recreational cyclists. Furthermore, we explored the impact of this polymorphism on circulating caffeine concentrations during acute exercise. Methods: Twenty subjects (13 males, 7 females) who reported non-to-moderate caffeine usage visited the Exercise Science Laboratory on three occasions. During the first visit, subjects underwent a graded exercise test to determine maximal oxygen consumption (VO2max). A venous blood sample was then obtained for genotyping analysis through polymerase chain reaction and gel electrophoresis. For the next two visits, three pieces of chewing gum (caffeine vs. placebo) were administered in a counterbalanced double blind manner. Subjects remained resting for 10 min and then completed a standard warm-up on a Lode cycle ergometer. Following the warm-up, subjects cycled at 75% VO2max (constant Wattage) for 15 min, rested for 10 min, and then completed a 15-min performance ride. Venous blood samples were collected at baseline (Base), during the warm-up (+25), and immediately before (+50) and after (+65) the performance ride. Serum samples were analyzed for caffeine concentrations through high-performance liquid chromatography. Subjects were grouped based on genotype and performance, and serum caffeine data were analyzed through a repeated-measures analysis of variance (ANOVA). Results: Eleven subjects possessed the AA genotype, while nine subjects were C allele carriers. Independent samples t-tests confirmed that groups were of similar age, body mass, and fitness. The data demonstrated that performance enhancement with caffeine treatment was not evident in this subject population (p ≥ 0.258). Furthermore, the ANOVA demonstrated that ergogenic responses to caffeine did not differ across genotype groups (p ≥ 0.861). Finally, circulating caffeine concentrations were similar across groups with caffeine treatment (p = 0.613). Conclusions: We conclude that a polymorphism in the cytochrome P450 CYP1A2 gene did not impact the ergogenic benefit of caffeine in recreational cyclists. Furthermore, circulating caffeine concentrations did not differ across genotype groups during acute exercise with caffeine treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490
Kamimori, G. H., Karyekar, C. S., Otterstetter, R., Cox, D. S., Balkin, T. J., Belenky, G. L., & Eddington, N. D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00958-9 · Cited by 449 · cited 1×
“24 Thus, it was anticipated that subjects ingested * 255 mg of caffeine.”
The absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378
Caffeine disposition after oral doses
Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.132 · Cited by 353 · cited 1×
“23 29 Caffeine is metabolized primarily in the liver through the cytochrome P450 system.”
Effect of different protocols of caffeine intake on metabolism and endurance performance
Cox, G. R., Desbrow, B., Montgomery, P. G., Anderson, M. E., Bruce, C. R., Macrides, T. A., Martin, D. T., Moquin, A., Roberts, A., Hawley, J. A., et al. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2002 · Cited by 309
Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers
Bell, D. G., & McLellan, T. M. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00187.2002 · Cited by 288
Metabolic, catecholamine, and endurance responses to caffeine during intense exercise
Jackman, M., Wendling, P., Friars, D., & Graham, T. E. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.4.1658 · Cited by 207
The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine
Womack, C. J., Saunders, M. J., Bechtel, M. K., Bolton, D. J., Martin, M., Luden, N. D., Dunham, W., & Hancock, M. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-7 · Cited by 178
Effect of Repeated Caffeine Ingestion on Repeated Exhaustive Exercise Endurance
BELL, D. G., & MCLELLAN, T. M. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000079071.92647.f2 · Cited by 92
Caffeine Gum and Cycling Performance: A Timing Study
Ryan, E. J., Kim, C.-H., Fickes, E. J., Williamson, M., Muller, M. D., Barkley, J. E., Gunstad, J., & Glickman, E. L. (2013) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3182541d03 · Cited by 73
Self-citationJacobson, T. L., Febbraio, M. A., Arkinstall, M. J., & Hawley, J. A. (2001) · Experimental Physiology · doi:10.1113/eph8602072 · Cited by 73 · cited 1×
“19 While methodological differences, in part, explain these equivocal findings, it is important to note that interindividual variability in the ergogenic benefit of caffeine has been reported.”
Caffeine Ingestion Prior to Incremental Cycling to Exhaustion in Recreational Cyclists
Flinn, S., Gregory, J., Mc Naughton, L., Tristram, S., & Davies, P. (1990) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024789 · Cited by 69
Cited by
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes
GUEST, N., COREY, P., VESCOVI, J., & EL-SOHEMY, A. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001596 · Cited by 231
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine
Southward, K., Rutherfurd-Markwick, K., Badenhorst, C., & Ali, A. (2018) · Nutrients · doi:10.3390/nu10101352 · Cited by 81
Carswell, A. T., Howland, K., Martinez-Gonzalez, B., Baron, P., & Davison, G. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04384-8 · Cited by 61
Metadata
- Authors
- Algrain, H. A., Thomas, R. M., Carrillo, A. E., Ryan, E. J., Kim, C.-H., Lettan, R. B., & Ryan, E. J.
- Venue
- Journal of Caffeine Research
- Publisher
- SAGE Publications
- Published
- 2016-03
- Volume
- 6
- Issue
- 1
- Pages
- 34-39
- ISSN
- 2156-5368 (ISSN-L)
- 2156-5783
- OpenAlex
- W2224962943
- Cited by
- 44
- References
- 13
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.